Clinical trial
A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic…
NCT00149578 · National Health Research Institutes, Taiwan, Other · Unknown status
Key facts
| NCT number | NCT00149578 |
|---|---|
| Title | A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer |
| Official title | A Phase II Study of Induction Chemotherapy Followed by Concurrent Chemotherapy With Radiotherapy in Locally Advanced Pancreatic Cancer |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Collaborators | Chang Gung Memorial Hospital National Taiwan University Hospital Mackay Memorial Hospital China Medical University Hospital National Cheng-Kung University Hospital |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine Oxaliplatin 5FU and Leucovorin |
| Enrollment | 45 |
| Start date | Oct 1, 2004 |
| Completion | Oct 1, 2008 |
| First posted | Sep 8, 2005 |
| Last update posted | May 17, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: